• Save
3D Printing for Healthcare 2014-2024
 

Like this? Share it with your network

Share

3D Printing for Healthcare 2014-2024

on

  • 1,021 views

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website ...

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1184/3D-Printing-for-Healthcare-R-D-Industry-and-Market-2014-2024

Statistics

Views

Total Views
1,021
Views on SlideShare
1,021
Embed Views
0

Actions

Likes
3
Downloads
14
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

3D Printing for Healthcare 2014-2024 Document Transcript

  • 1. 3D Printing for Healthcare: R&D, Industry and Market 2014-2024 ©notice This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.
  • 2. Contents 1. Executive Summary 1.1 What This Report Covers 1.2 Overview of 3D Printing for Healthcare: Industry and Market 2014-2024 1.3 Chapter Outlines 1.4 Research and Analysis Methods 2. An Introduction to 3D Printing for the Healthcare Industry 2.1 3D Printing 2.1.1 The Original 3D Printing Process 2.1.2 Selective Laser Sintering (SLS) 2.1.3 Direct Metal Laser Sintering (DMLS) 2.1.4 Electron Beam Melting (EBM) 2.1.5 Stereolithography (SLA) 2.2 Bioprinting: The Printing of Living Cells 2.2.1 How 3D Printing With Living Tissue Works 2.2.2 The Near- and Long-Term Applications for 3D Bioprinting 2.2.3 Current Problems With 3D Bioprinting 2.3 The 3D Printing of Pharmaceuticals 2.3.1 3D Printing Technology in Drug Discovery 2.4 Classifying Medical Devices 2.4.1 The US Medical Devices Classification System 2.4.2 The EU Medical Devices Classification System 3. The 3D Printing Market for the Healthcare Industry, 2014-2024 3.1 The 3D Printing Market for Healthcare in 2012: Technology vs. Products www.visiongain.com
  • 3. Contents 3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application 3.3 The 3D Printing Market for Healthcare: An Overarching Revenue Forecast 2014-2024 3.4 The Driving and Restraining Factors of the Industry 3.5 3D Printing Technology for Healthcare: Revenue Forecast 2014-2024 3.6 3D Printed Products for Healthcare by Application: Revenue Forecast 2014-2024 3.6.1 Dental Products Dominated the 3D Printed Products Market in 2012, But Will This Continue? 3.6.2 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology 3.6.2.1 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2013 3.6.3 Bioprinted Tissue: Commercial Launch Anticipated in 2014 3.6.4 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals 4. The Leading National Markets for 3D Printing for Healthcare, 2014-2024 4.1 A Geographical Breakdown of 3D Printing Technology Manufacturers for the Healthcare Industry, 2012 4.2 The Leading National Markets for 3D Printing in Healthcare, 2012 4.3 The Leading National Markets: Comparison of Revenue and Market Share, 2018 and 2024 4.4 The Leading National Pharmaceutical Markets for 3D Printing for Healthcare: A Grouped Revenue Forecast, 2014-2024 4.5 The US Will Continue to be the Largest Consumer Throughout the Forecast Period 4.5.1 Pioneering Use of 3D Printed Medical Implants in the US 4.5.2 FDA Regulatory Requirements: Abridged Pathways Foster Innovation www.visiongain.com
  • 4. Contents 4.6 The EU5 Account for 30% of the Market in 2012, But How Will This Change During the Forecast Period 2014-2024? 4.6.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period 4.6.2 France: Strong Growth but a Decreasing Market Share 4.6.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products 4.6.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM Technology 4.6.5 Spain: the Smallest of the EU5 Will See the Highest Growth 4.7 Japan: Growth Will be Driven by Domestic as well as International Innovation 4.8 China: Domestic Innovation is Keeping Pace With the Western World 4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing 4.10 The Indian Market is at an Early Stage 4.11 Will 3D Printing Penetrate the Russian Healthcare Market? 5. 3D Printing for Healthcare: Leading Organisations in the Market 5.1 Leading Organisations in the Industry, 2013-2014 5.2 Organisations in the Medical Implants Sector 5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants 5.2.2 Oxford Performance Materials: Selling 3D Printed Implants Since Late 2011 5.2.3 Within Technologies: A Manufacturer of Software for 3D Printing 5.2.3.1 Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program 5.2.3.2 The Future of Within Technologies in the Medical Field www.visiongain.com
  • 5. Contents 5.2.4 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields 5.2.5 Tonrud Engineering: A Provider of DMSL Since November 2011 5.2.6 Alphaform AG’s Two Business Segments Will Grow Synergistically 5.2.7 3T RPD Ltd: A UK-Based Additive Manufacturing Company 5.2.8 EOS: A Manufacturer of 3D Printers 5.2.9 Arcam AB is Seeing Rapid Growth in 2013 5.2.10 Xilloc Medical: Specialising in Patient-Specific Implants 5.2.11 LayerWise: A Specialist in Metal Additive Manufacturing 5.2.12 3D Systems: High Rates of Growth in the Healthcare Industry 5.2.13 Stratasys: Merged With Objet in December 2012 5.3 Organisations in the 3D Bioprinting Sector 5.3.1 Wake Forest Institute for Regenerative Medicine: Working to Engineer >30 Tissues and Organs Using 3D Printing 5.3.1.1 Timeline for Commercially Available Therapeutic Applications 5.3.1.2 Commercial Applications of the Technology in Drug Development 5.3.2 Organovo: An Early Stage Regenerative Medicine Company 5.4 Organisations in Other Industry Sectors 5.4.1 Aprecia Pharmaceuticals: A Unique Oral Drug Delivery System Produced by 3D Printing Technology 5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals 5.4.3 EnvisionTEC Provides Seven 3D Printing Systems for a Variety of Applications in the Medical and Dental Industries 5.4.4 Materialise NV: 3D Printing Medical Models www.visiongain.com
  • 6. Contents 6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 20132014 6.1 R&D in the Field of Medical Implants 6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2 6.1.2 3D Printing Intervertebral Discs Could Look Forward to a Share of a $90bn Market 6.1.3 3D Printing of Bionic Organs With Enhanced Functionality 6.2 R&D in the Field of Bioengineering 6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years? 6.2.2 The Production of Implantable Cartilage Using 3D Printing 6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs 6.2.3.1 Work at the University of Pennsylvania and MIT 6.2.3.2 Work at Fraunhofer 6.2.4 3D Printing of Functioning Livers at Organovo 6.2.5 3D Printing of Replacement Ears for Reconstructive Surgery 6.2.6 3D Printing to Fabricate Artificial Heart Valves 6.2.7 3D Printing Miniature Spheres With a Lipid Bilayer: Mimicking the Membranes of Living Cells 6.3 R&D in Other Fields 6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World? 7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2013-2014 Onwards 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare at the End of 2013 7.1.1 The Market is in a High Growth Phase www.visiongain.com
  • 7. Contents 7.1.2 AM Has a Smaller Resource Footprint 7.1.3 Customised Implants are in High Demand 7.1.4 Producing Complex Shapes and Parts 7.1.5 With High Volume, the Technology is Inefficient 7.1.6 3D Printing Remains Expensive 7.1.7 The Impact of the Adoption of 3D Printing on Jobs in Medical Manufacturing Industries 7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024 7.2.1 Uses of 3D Printing in the Healthcare Industry Expand 7.2.2 The Demand for Personalised Medicine Represents a Lucrative Opportunity 7.2.3 There Exists Much Governmental Investment in the Technologies 7.2.4 Opportunities in Post-Production Finishing 7.2.5 Threats Posed by Questions Over Legal Responsibility and Rights 7.2.6 Threats Posed by Alternative Manufacturing Methods 7.3 The Social, Technological, Economic and Political Factors Influencing the 3D Printing Industry for Healthcare, 2014-2024 7.3.1 Social Influences on Market Trends 7.3.2 Technological Influences on Market Trends 7.3.3 Economic Influences on the Market 7.3.4 Political Influences on the Market 8. Research Interviews 8.1 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys 8.1.1 On Stratasys’ Offerings for the Healthcare Industry www.visiongain.com
  • 8. Contents 8.1.2 On the Demand for 3D Printing in Healthcare 8.1.3 On the Future of 3D Printing in the Healthcare Industry 8.2 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover 8.2.1 On Laser-Assisted BioPrinting 8.2.2 On the Uses of 3D Printed Tissue 8.2.3 On 3D Printed Tissue vs. Traditional In Vitro Models 8.2.4 On 3D Printed Tissue for Transplantation 8.2.5 On Research in the Field 8.2.6 On the Timeline for Commercial Availability 8.3 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo 8.3.1 On the Applications for 3D Bioprinting 8.3.2 On the Commercial Prospects of the Technology 8.3.3 On Potential Factors That Could Inhibit Development 8.3.4 On the Timeline for the Use of Bioprinted Tissues in Therapy 9. Conclusions from Our Study 9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2014-2024 9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2012, 2018 and 2024 9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2014-2024 9.4 Trends in the Industry and Market 9.4.1 3D Printing Technology is Already Established in the Field of Dentistry 9.4.2 The Uptake of 3D Printed Orthopaedic Implants is Gathering Pace 9.4.3 An Increasing Focus on Bioprinting www.visiongain.com
  • 9. Contents 9.4.4 Demand for Technology Corresponds With the Demand for Products www.visiongain.com
  • 10. Contents List of Tables Table 1.1 Currency Exchange Rates Table 2.1 The US Classification of Medical Devices Table 2.2 The EU Classification of Medical Devices Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2012 Table 3.2 3D Printed Products for Healthcare by Application: Revenues ($m) and Market Shares (%), 2012 Table 3.3 3D Printing in the Healthcare Industry by Submarket: Revenue ($m) and Market Share (%) Forecasts, 2013-2024 Table 3.4 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024 Table 3.5 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2013-2024 Table 3.6 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 3.7 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 20132024 Table 3.8 Bioprinted Tissue: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 3.9 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare: Revenue ($m) and Market Share (%) by Region, 2012 Table 4.2 Leading National Markets for 3D Printing Technology and 3D Printed Products for Healthcare: Revenue ($m) and Market Share (%), 2012 Table 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2018 and 2024 Table 4.4 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Revenue Forecasts ($m), 2013-2024 www.visiongain.com
  • 11. Contents Table 4.5 The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.6 The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2013-2024 Table 4.7 The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.8 The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.9 The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.10 The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.11 The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.12 The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.13 The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.14 The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 4.16 The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 Table 5.1 Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of 2013 Table 5.2 Prominent Organisations in the Medical Implant Market, End of 2013 www.visiongain.com
  • 12. Contents Table 5.3 Medical Implants Designed by Within Technologies' Software, 2013 Table 5.4 Alphaform: Breakdown of Revenue ($m, %) by Business Segment, 2012 Table 5.5 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 19972012 Table 5.6 Materials Used by Xilloc Medical, 2013 Table 5.7 The Main Organisations 3D Bioprinting Market, 2013 Table 5.8 Prominent Organisations in Other Industry Sectors Using 3D Printing, 2013 Table 5.9 EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2013 Table 6.1 Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2013 Table 6.2 3D Printing Intervertebral Discs: Main Facts, 2013 Table 6.3 3D Printing of Bionic Organs: Main Facts, 2013 Table 6.4 3D Printing of Skin Grafts: Main Facts, 2013 Table 6.5 3D Printed Cartilage: Main Facts, 2013 Table 6.6 3D Printing of Blood Vessels: Main Facts, 2013 Table 6.7 3D Printing of Functioning Liver Tissue: Main Facts, 2013 Table 6.8 3D Printing of Replacement Human Ears: Main Facts, 2013 Table 6.9 3D Printing of Heart Valves: Main Facts, 2013 Table 6.10 3D Printing of Material That Mimics Living Cells: Main Facts, 2013 Table 6.11 3D Printing of Pharmaceuticals: Main Facts, 2013 Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2013-2014 Table 7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024 Table 7.3 STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D Printing Market for Healthcare, 2014-2024 www.visiongain.com
  • 13. Contents List of Figures Figure 3.1 Breakdown of the Market by Technology and Products: Market Share (%), 2012 Figure 3.2 3D Printed Products for Healthcare by Application: Market Share (%), 2012 Figure 3.3 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 20132024 Figure 3.4 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2018 Figure 3.5 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2024 Figure 3.6 Driving and Restraining Factors of 3D Printing for Healthcare, 2014 Figure 3.7 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 3.8 Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry, 2014 Figure 3.9 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 20132024 Figure 3.10 3D Printed Products by Application: Market Share (%), 2018 Figure 3.11 3D Printed Products by Application: Market Share (%), 2024 Figure 3.12 3D Printed Dental Products: Revenue Forecast ($m), 2013-2024 Figure 3.13 Driving and Restraining Factors of the 3D Printed Dental Product Market, 2014 Figure 3.14 3D Printed Medical Implants: Revenue Forecast ($m), 2013-2024 Figure 3.15 Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2014 Figure 3.16 Bioprinted Tissue: Revenue Forecast ($m), 2013-2024 Figure 3.17 Driving and Restraining Factors of the 3D Bioprinting Market, 2014 Figure 3.18 Other Applications: Revenue Forecast ($m), 2013-2024 Figure 3.19 Driving and Restraining Factors of the Market for Other Applications, 2014 Figure 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare: Market Share by Region (%), 2012 www.visiongain.com
  • 14. Contents Figure 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2012 Figure 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2018 Figure 4.4 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2024 Figure 4.5 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Grouped Revenue Forecast ($m), 2013-2024 Figure 4.6 The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.7 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2012 Figure 4.8 The EU5: National Revenue Forecasts ($m), 2013-2024 Figure 4.9 The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.10 The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.11 The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.12 The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.13 The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.14 The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.15 The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.16 The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.17 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 Figure 4.18 The Russian 3D Printing Market For Healthcare: Revenue Forecast ($m), 2013-2024 Figure 5.1 Alphaform: Geographical Distribution of Revenue, 1H2013 Figure 5.2 Alphaform: Breakdown of Revenue by Business Segment (%), 2012 Figure 5.3 Arcam: Breakdown of System Sales by Industry, 1997-2012 www.visiongain.com
  • 15. Contents Figure 5.4 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2012 Figure 5.5 3D Systems: Breakdown of Revenue by Industry, 3Q 2013 Figure 6.1 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2013 Figure 8.1 Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer Figure 8.2 VeinViewer® Flex designed Using Stratasys 3D Printed Prototypes Figure 8.3 VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand Figure 8.4 Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D CTI), Shows 12-year-old Boy’s Skull Model Produced on an Objet350 Connex Multi-material 3D Printer Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Into Technology and Products, 2013-2024 Figure 9.2 3D Printed Products for the Healthcare Industry by Application: Comparisons of Revenue ($m), 2012, 2018 and 2024 Figure 9.3 The Leading National Markets in the 3D Printing Industry for Healthcare: Comparison of Revenue ($m), 2012, 2018 and 2024 www.visiongain.com
  • 16. Contents Companies and Organisations Mentioned in the Report 3D Systems Corp 3T RPD 5N Plus Adler Ortho Alphaform AG Aprecia Pharmaceuticals Arcam AB Asian Manufacturing Association (AMA) BestinClass SA Biomet C&A Tool Chinese FDA (CFDA) Clemson University Compass3D Conformité Européenne (CE) Cornell University Deloitte DePuy Synthes Deutsches Herzzentrum Berlin (DHZB) DiSanto Technology EnvisionTEC EOS Ernst & Young www.visiongain.com
  • 17. Contents Expert 3D Solutions FirstSurface Ltd. Food and Drug Administration (US FDA) Fraunhofer Institutes Hangzhou Dianzi University Harvard University Imaginarium Industry Alliance of China 3D Printing Technology Invetech Johns Hopkins University Knight Cancer Institute Kyoto University Laser Zentrum Hannover LayerWise Lexmark Lima Corporate Maastricht Instruments B.V. Massachusetts Institute of Technology (MIT) Materialise NV Mattel Children’s Hospital MCP HEK Tooling Medical Modelling Medimet GMBH Medtronic Michael J Fox Foundation www.visiongain.com
  • 18. Contents Ministry of Industry and Information Technology Nakashima Medical National Additive Manufacturing Innovation Institute (NAMII) North Carolina State University Nottingham University Hospitals Trust Objet OBL Office of Science and Engineering Laboratories Oregon Health and Science University Organovo Oxford Performance Materials (OPM) Peking University 3rd Hospital Pfizer Princeton University Protosys Technologies Queen’s Medical Centre (QMC) Roche Royal Perth Hospital, Australia SIU System SkinPrint Smith & Nephew Sony DADC State Food and Drug Administration (SFDA) Stratasys Stryker www.visiongain.com
  • 19. Contents The Cronin Group The Michael J Fox Foundation Tissue Regeneration Systems Tonrud TU Berlin UCLA United Therapeutics University of Glasgow University of Michigan University of North Carolina University of Oxford University of Pennsylvania University of Wisconsin Wake Forest Institute for Regenerative Medicine (WFIRM) Walter Reed National Military Medical Center Weill Cornell Medical College Within Technologies Wyss Institute for Biologically Inspired Engineering Xilloc Medical Zimmer www.visiongain.com
  • 20. 3D Printing for Healthcare - R&D, Industry and Market 2014-2024 market for healthcare will expand at a CAGR of 14.89%. In 2024, sales of 3D printing technology and 3D printed products for healthcare in Brazil will generate $169m, accounting for 1.98% of the global market. 4.10 The Indian Market is at an Early Stage In 2012, sales of 3D printing technology and 3D printed products for healthcare in India generated revenue of $14m, accounting for 1.3% of the world market. 3D printing is at an early stage in this region. At present, the most significant application of 3D printing in the Indian healthcare sector is the production of prototypes and medical models. There are several companies which offer this service, including Protosys Technologies and Imaginarium. Mumbai-based Protosys Technologies was established in 1996 and provides stereolithography, selective laser sintering and fused deposition modelling, as well as basic 3D printing for a range of industries. However, the field of medicine is an important focus. The company has been providing medical models for surgeons since 2000, it is reported. These medical models can be produced in under one week and allow surgeons to more effectively visualise the trauma, plan surgical procedures, reduce surgery time, and design custom implants for the patient. As healthcare spending in India increases over the forecast period and knowledge of the benefits of medical modelling increase, demand for these 3D printed products will increase. Imaginarium is India’s largest provider of 3D printing, that company reports, providing rapid prototyping and rapid manufacturing. Imaginarium provides 3D printing solutions to the medical manufacturing industry and medical professionals in India, including prototyping and low volume production of medical devices. These include dental, orthopaedic and cranio-maxillofacial implants, surgical guides, custom prosthetics and anatomical models. Imaginarium has been established for over 30 years, but the application of the company’s services to the medical industry is relatively new. The market is in an early stage at present. However, the demand for 3D printed medical and dental implants will increase rapidly during the forecast period 2014-2024 as knowledge and affordability of the technology increases. Healthcare spending in the country is set to increase, with a key focus th of the government’s 12 five-year-plan 2012-2017 on a thrust in the medical industry. This will drive the uptake of new technology, such as 3D printing, we believe. However, this uptake will be restrained by the high cost of 3D printing technology and the raw materials required. Between 2012 and 2018, the Indian market for 3D printing for healthcare will expand at a CAGR of 26.1%. This rate of growth will slow towards the end of the forecast period, restrained by the high www.visiongain.com Page 85
  • 21. 3D Printing for Healthcare - R&D, Industry and Market 2014-2024 cost of the technology and the continued prominence of other manufacturing methods in the medical implants market. The penetration of 3D printed medical implants will slow. Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Market Share (%) 1.30 1.32 1.34 1.36 1.38 1.40 1.44 1.48 1.52 1.56 1.60 1.64 1.68 Revenue ($m) 14 17 19 23 30 42 58 81 96 110 120 131 144 AGR (%) 15 16 18 32 39 39 40 18 15 9 9 9 CAGR (%) 26.10 16.24 Source: visiongain 2014; CAGR values for year ranges 2012-2018 and 2018-2024 Figure 4.17 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024 160 140 Revenue ($m) 120 100 80 60 40 20 0 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Year Source: visiongain 2014 Between 2018 and 2024, the Indian market for 3D printing for healthcare will expand at a CAGR of 16.24%. In 2024, sales of 3D printing technology and 3D printed products for healthcare in India will generate $144m, accounting for 1.68% of the global market. 4.11 Will 3D Printing Penetrate the Russian Healthcare Market? In 2012, sales of 3D printing technology and 3D printed products for healthcare in Russia generated revenue of $18m, accounting for 1.6% of the global market, visiongain estimates. Over the course of the forecast period 2014-2024, this market will see strong growth as knowledge regarding the capabilities and advantages of 3D printing spread and healthcare spending www.visiongain.com Page 86